ARMP
Armata Pharmaceuticals, Inc.
+0.13 (+3.19%)4.20USD73.4K成交股數156M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 7.6M | 6.1M | 6.1M | 5.8M | 6.4M | 5.4M | 9.5M | 8.5M | 8.0M | 7.9M | 8.0M | 8.3M |
| 銷售管理費用 | 5.2M | 3.5M | 3.4M | 3.1M | 2.6M | 3.3M | 3.2M | 3.4M | 3.2M | 3.2M | 3.6M | 2.4M |
| 營業利益 | −10.3M+51% | −8.8M+7% | −13.8M+42% | −7.8M-35% | −6.8M-33% | −8.2M-14% | −9.8M-6% | −11.9M+24% | −10.2M | −9.6M | −10.3M | −9.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 74.1M-555% | −115M+1666% | −124M+2168% | −26.7M-397% | −16.3M-35% | −6.5M-67% | −5.5M-82% | 9.0M-353% | −25.0M | −19.8M | −31.2M | −3.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.27-40% | -3.16+1480% | -3.41+2173% | -0.74+196% | -0.45-35% | -0.20-58% | -0.15-83% | -0.25+47% | -0.69 | -0.48 | -0.86 | -0.17 |
| 稀釋股數 | 62.0M | 36.5M | 36.2M | 36.2M | 36.2M | 59.5M | 36.2M | 58.2M | 36.1M | 36.1M | 36.1M | 56.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.0M | 4.8M | 8.7M | 14.8M | 4.3M | 11.7M | 17.1M | 26.4M | 37.9M | 13.5M | 24.0M | 12.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 90.0M | 69.8M | 76.9M | 89.5M | 80.8M | 87.3M | 98.2M | 108M | 120M | 98.4M | 113M | 101M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 321M | 381M | 295M | 185M | 150M | 141M | 149M | 154M | 177M | 130M | 125M | 82.1M |
| 股東權益 | −231M | −312M | −219M | −95.6M | −69.5M | −53.8M | −51.0M | −46.1M | −56.5M | −32.1M | −12.4M | 19.1M |
| 負債比 | 357.0% | 546.4% | 384.3% | 206.8% | 186.0% | 161.6% | 151.9% | 142.6% | 147.0% | 132.6% | 111.0% | 81.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.8M-24% | – | – | – | −7.6M | – | – | −10.6M | – | – | – |
| 資本支出 | – | 63K | – | – | – | 99K | – | – | 250K | – | – | – |
| 自由現金流 | – | −5.8M-24% | – | – | – | −7.7M | – | – | −10.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | 377K | – | – | 317K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −174M | –% | -4.80 | −26.3M |
| FY2024 | – | – | −18.9M | –% | -0.89 | −39.4M |
| FY2023 | – | – | −69.0M | –% | -1.91 | −55.6M |
| FY2022 | – | – | −36.9M | –% | -1.08 | −34.7M |
| FY2021 | – | – | −23.2M | –% | -0.96 | −24.9M |
| FY2020 | – | – | −22.2M | –% | -1.35 | −19.1M |
| FY2019 | – | – | −19.5M | –% | -2.55 | −15.8M |
| FY2018 | – | – | −16.7M | –% | -3.59 | −11.5M |